Dongrui Ma

5PUBLICATIONS
14CO-AUTHORS
Gene and molecular therapyPharmacogenomicsPharmaceutical delivery technologiesGenetically modified treesAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Correction: Ti et al. Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation. Int. J. Mol. Sci. 2026, 27, 6254.

|Jul 28, 2026
Blood-Based α-Synuclein Biomarkers in Parkinson's Disease: Molecular Diversity, Analytical Advances and Clinical Translation.

|Jun 30, 2025
Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson's Disease Pathogenesis and Drug Screening.

Jihong Liu, Wanlin Zhao, Zijuan Zhang

|Aug 23, 2022
The APP intracellular domain promotes LRRK2 expression to enable feed-forward neurodegenerative mechanisms in Parkinson's disease.

Zhi-Wei Zhang, Haitao Tu, Mei Jiang

|Jul 28, 2018
Identification of an INa-dependent and Ito-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patient.

Dongrui Ma, Zhenfeng Liu, Li Jun Loh

Pageof 1

Frequent Collaborators

2 joint publications

Kailiang Ti

1 joint publications

Zhi-Wei Zhang

1 joint publications

Haitao Tu

1 joint publications

Sarivin Vanan